This summer, the American Diabetes Association partnered with IBM Watson Health to bring together the cognitive computing power of Watson and the Association’s vast repository of clinical and research data.
Consumers are learning for the first time that they may be diabetic or prediabetic from their neighborhood pharmacist as opposed to their primary care doctors with the advent of complimentary health screenings available through a growing number of retail health fairs.
Even though the number of new diagnoses each year is trending down, diabetes is still a prevalent chronic disease in the United States. If left unchecked, one person out of every three will be diabetic by the time millennials collect Social Security.
In 2017, how people shop, why people shop and what they’re shopping for will all be shaped by two overarching themes — access to digitized health information and wearables, as well as other Bluetooth-enabled, diagnostic-style self-care offerings.
There are definitely several themes playing out across Drug Store News’ top 10 list of breakthrough brands, defined by those brands that have contributed the most impactful growth over an annualized period, in this case for the 52 weeks ended Oct. 2 across total U.S. multi-outlets, according to IRI.
Univision Communications Inc., in partnership with Nielsen, in October took a deep dive into how Hispanics buy and shop the self-care aisles. They are an important demographic for OTC purveyors — they have larger households than average; they’re more brand loyal; and they’re not only younger than the average American, but also have a longer life expectancy.
Sales of OTC medicines continued on a strong growth trajectory of more than 3%, growing by approximately $1.4 billion in dollar volume to $45.6 billion for the 52 weeks ended Oct. 2, according to IRI data. And that’s primarily organic growth from existing brands.